| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | INFUSION OF THERAPEUTIC AGENTS TO THE BRAIN (CONVECTION-ENHANCED INTRAPARENCHYMAL DELIVERY) - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2193214 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | METHODS TO MEASURE BODY COMPOSITION (E.G., DXA, BIA AND ADP) - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2208621 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | CAR-T CLASS POLICY (policy retired as of 8/12/2021 ML)PayerPolicy · BCBSM-2065125 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | GENETIC TESTING-NON-INVASIVE PRENATAL TESTING FOR FETAL RBC ANTIGEN STATUSPayerPolicy · BCBSM-2062781 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | GENETIC TESTING - WHOLE EXOME AND WHOLE GENOME SEQUENCING FOR DIAGNOSIS OF GENETIC DISORDERSPayerPolicy · BCBSM-2034822 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | AUTOMATED VISUAL EVOKED POTENTIALS FOR ROUTINE VISION SCREENING IN PEDIATRICS - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2191156 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | 90584 DENGUE VACCINE, QUADRIVALENT, LIVE, 2 DOSE SCHEDULE, FOR SUBCUTANEOUS USEPayerPolicy · BCBSM-2166072 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | LABORATORY TESTS POST TRANSPLANT (KIDNEY AND HEART) AND FOR HEART FAILURE - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2198915 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | GALECTIN-3 TESTING IN THE ASSESSMENT AND MANAGEMENT OF CHRONIC HEART FAILURE - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2201428 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | GENETIC TESTING - MOLECULAR GENOMIC PROFILING FOR CANCERS OF UNKNOWN PRIMARY (CUP) ORIGINPayerPolicy · BCBSM-2007398 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | ELELYSO (TALIGLUCERASE) ENZYME REPLACEMENT THERAPY (J3060) retired as of 10/8/2020PayerPolicy · BCBSM-2132014 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | METHOTREXATE (MTX) POLYGLUTAMATE TESTING TO MEASURE RESPONSE TO METHOTREXATE THERAPY - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2193867 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | GENETIC TESTING (SINGLE NUCLEOTIDE VARIANTS) TO PREDICT RISK OF NONFAMILIAL BREAST CANCERPayerPolicy · BCBSM-2106372 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | CHARGED-PARTICLE (PROTON OR HELIUM ION) RADIOTHERAPY FOR NEOPLASTIC CONDITIONS - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2196069 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | SEMI-IMPLANTABLE AND FULLY IMPLANTABLE MIDDLE EAR HEARING AIDS - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2194712 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | BONE GROWTH STIMULATION: ELECTRICAL STIMULATION OF THE SPINE AS AN ADJUNCT TO SPINAL FUSION PROCEDURESPayerPolicy · BCBSM-2029504 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | INTENSITY-MODULATED RADIATION THERAPY (IMRT): ABDOMEN, PELVIS, AND CHEST - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2193858-4C26481994 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | THERAPEUTIC LIGHT BOX FOR THE TREATMENT OF MAJOR DEPRESSION WITH SEASONAL PATTERN - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2195979 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | CARDIAC CONTRACTILITY MODULATION (I.E., OPTIMIZER SMART) FOR THE TREATMENT OF HEART FAILUREPayerPolicy · BCBSM-2197466 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | ENDOTHELIAL FUNCTION ASSESSMENT( policy retired effective 09/01/2019)PayerPolicy · BCBSM-2041205 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | GENETIC TESTING FOR ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY/DYSPLASIA (ARVC/D)PayerPolicy · BCBSM-2007395 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | HOME MONITORING DEVICE FOR AGE-RELATED MACULAR DEGENERATION - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2193213 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | BCN ONLY - SPEECH AND SWALLOWING THERAPY (replaced by Doc ID 2175952)PayerPolicy · BCBSM-2008113 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | TRANSCRANIAL MAGNETIC STIMULATION AS A TREATMENT OF DEPRESSION AND OTHER PSYCHIATRIC/NEUROLOGIC DISORDERSPayerPolicy · BCBSM-77020 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | INTRAOCULAR RADIATION THERAPY FOR AGE-RELATED MACULAR DEGENERATION - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2193860 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | SERUM BIOMARKER HUMAN EPIDIDYMIS PROTEIN 4 (HE4) - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2198899 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | NONTRADITIONAL BIOMARKERS IN RISK ASSESSMENT AND MANAGEMENT OF CARDIOVASCULAR DISEASE- MEDICARE ADVANTAGEPayerPolicy · BCBSM-2205378 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | AIM MEDICAL POLICY - INOTUZUMAB OZOGAMICIN: BESPONSA (J9229) (RETIRED AS OF 02/02/2023)PayerPolicy · BCBSM-2091529 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | FOSNETUPITANT PALONOSETRON INJECTION: AKYNZEO (C9033) RETIRED AS OF 10/8/2020PayerPolicy · BCBSM-2099264 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | GENETIC TESTING FOR TAY-SACHS DISEASE (EFFECTIVE 07/01/2026)PayerPolicy · BCBSM-2209357-AB8E3155A0 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | AIM MEDICAL POLICY - LUMOXITI (MOXETUMOMAB PASUDOTOX-TDFK) (retired as 10/12/2023)PayerPolicy · BCBSM-2103567 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | PROSTATE CANCER EARLY DETECTION: BIOMARKERS PRIOR TO BIOPSY - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2198893 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | GENE EXPRESSION PROFILE ANALYSIS FOR RISK STRATIFICATION FOR PROSTATE CANCER MANAGEMENTPayerPolicy · BCBSM-2065123 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | GROWING RODS FOR SCOLIOSIS (E.G., MAGEC SPINAL BRACING AND DISTRACTION SYSTEM)PayerPolicy · BCBSM-2108870 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | COMPUTER-AIDED EVALUATION AS AN ADJUNCT TO MAGNETIC RESONANCE IMAGING FOR PROSTATE CANCERPayerPolicy · BCBSM-2187369 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | IMPLANTABLE BONE-CONDUCTION AND BONE-ANCHORED HEARING DEVICES - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2193812 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | BMT- HEMATOPOIETIC CELL TRANSPLANTATION (HCT) FOR CNS EMBRYONAL TUMORS AND EPENDYMOMAPayerPolicy · BCBSM-2022264 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | MAGNETIC ESOPHAGEAL SPHINCTER AUGMENTATION TO TREAT GASTROESOPHAGEAL REFLUX DISEASE (GERD)PayerPolicy · BCBSM-2032188 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | SERUM MARKERS FOR THE DIAGNOSIS AND CARE OF INFLAMMATORY BOWEL DISEASE - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2198900 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | LABORATORY TESTS POST TRANSPLANT (KIDNEY, HEART AND LUNG) AND FOR HEART FAILUREPayerPolicy · BCBSM-104426 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | EYE MOVEMENT DESENSITIZATION AND REPROCESSING FOR POST TRAUMATIC STRESS DISORDER (PTSD)PayerPolicy · BCBSM-2017931 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | BMT - HEMATOPOIETIC CELL TRANSPLANTATION FOR GERM-CELL TUMORS - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2195788 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | POSTSURGICAL HOME USE OF LIMB COMPRESSION DEVICES FOR VENOUS THROMBOEMBOLISM PROPHYLAXISPayerPolicy · BCBSM-2030257 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | MENISCAL ALLOGRAFTS AND OTHER MENISCAL IMPLANTS (EFFECTIVE 07/01/2026)PayerPolicy · BCBSM-2209359-8FFEFCF3B6 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | SPEECH AND LANGUAGE PATHOLOGY/SWALLOWING REHABILITATION (EFFECTIVE 09/01/2026)PayerPolicy · BCBSM-2210511-6C589835B7 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | TRANSCUTANEOUS ELECTRICAL MODULATION PAIN REPROCESSING (SCRAMBLER THERAPY) - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2195920 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD), INCLUDING SUBCUTANEOUS ICDS AND SUBSTERNAL ICDSPayerPolicy · BCBSM-2197929 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | GENETIC TESTING-GENE EXPRESSION PROFILING FOR UVEAL MELANOMA - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2198881 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | BONE MARROW TRANSPLANT HEMATOPOIETIC CELL TRANSPLANTATION FOR EPITHELIAL OVARIAN CANCERPayerPolicy · BCBSM-2026842-9FD3019F20 | New policy |
|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | BRACHYTHERAPY FOR CLINICALLY LOCALIZED PROSTATE CANCER USING PERMANENTLY IMPLANTED SEEDSPayerPolicy · BCBSM-77460 | New policy |
|---|